RLV.v - Relevium Technologies

Discussion in 'Canadian Stocks Message Boards' started by SleekyTrader, Jan 27, 2017.

  1. SleekyTrader

    SleekyTrader Member

    Joined:
    Jul 21, 2016
    Messages:
    51
    Likes Received:
    0
    All I can say is WOW !

    According to the internal financial information supplied during the due diligence procedures, for the 12 month period ended September 30, 2016, BioGanix had total revenues of US$4M and net earnings of US$1.3M. At September 30, 2016, BioGanix had total assets of US$0.5M.
    Read more at http://www.stockhouse.com/news/pres...asset-with-us-1-3-million#PVES5GZxuSdZo2jX.99

    1.3M$ USD net earnings and only 3M$ CAD market cap ? Must be the most undervalued stock on the TSX-V by far

    34M shares out with 24M held by insiders. Float is only 10M shares
     
  2. SleekyTrader

    SleekyTrader Member

    Joined:
    Jul 21, 2016
    Messages:
    51
    Likes Received:
    0
    Currently trading at 0.12$
    At 10x PE we are looking at around 0.60$ on this deal alone without calculating growth etc...
    This will be fun to ride up
     
  3. SleekyTrader

    SleekyTrader Member

    Joined:
    Jul 21, 2016
    Messages:
    51
    Likes Received:
    0
    Anybody realize the opportunity here ? These come once every few years
     
  4. SleekyTrader

    SleekyTrader Member

    Joined:
    Jul 21, 2016
    Messages:
    51
    Likes Received:
    0
    Hummm, I guess I'm alone on this. I'll let you all know once the deal closes :)
     
  5. Epicram

    Epicram Member

    Joined:
    Oct 13, 2016
    Messages:
    111
    Likes Received:
    8
    I Agree with the above replies, there is huge opportunity in this stock in future.
     
  6. SleekyTrader

    SleekyTrader Member

    Joined:
    Jul 21, 2016
    Messages:
    51
    Likes Received:
    0
    Insider buying 100K
     
  7. SleekyTrader

    SleekyTrader Member

    Joined:
    Jul 21, 2016
    Messages:
    51
    Likes Received:
    0
    HEre we go folks, don't miss the train. 10 bagger in 2017 for these guys
     
  8. SleekyTrader

    SleekyTrader Member

    Joined:
    Jul 21, 2016
    Messages:
    51
    Likes Received:
    0
    Its doing lots of volume today, its gonna pop
     
  9. SleekyTrader

    SleekyTrader Member

    Joined:
    Jul 21, 2016
    Messages:
    51
    Likes Received:
    0
    Here we go folks +71% on over 7M volume
     
  10. SleekyTrader

    SleekyTrader Member

    Joined:
    Jul 21, 2016
    Messages:
    51
    Likes Received:
    0
    Anyone taking advantage ? we should break 0.20$ tomorrow
     
  11. SleekyTrader

    SleekyTrader Member

    Joined:
    Jul 21, 2016
    Messages:
    51
    Likes Received:
    0
    Looking very good here, should see 0.40$+ by month's end
     
  12. SleekyTrader

    SleekyTrader Member

    Joined:
    Jul 21, 2016
    Messages:
    51
    Likes Received:
    0
    Very nice consolidation here in the 0.12$ range. Stock is now ready for the next leg up. Expect new highs as we get closer than ever to the deal being signe
     
  13. shellybear

    shellybear Member

    Joined:
    Feb 11, 2017
    Messages:
    122
    Likes Received:
    9
    This is a LOI? and they need to come up with 2.7 Million $ US to get this deal going?
    RLV needs to have a big financing? Great trading stock of late tho, looking at the volume and interest in the stock.
     
  14. SleekyTrader

    SleekyTrader Member

    Joined:
    Jul 21, 2016
    Messages:
    51
    Likes Received:
    0
    The deal is pretty much closed, just waiting for TSXV approval really. Huge news on Friday, ducks are lined up. This stock on valuation of earnings alone is worth over 0.50$ once the deal officially closes with say a 0.10$ financing


    MONTREAL, QUEBEC--(Marketwired - Feb. 10, 2017) - Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness in conjunction with its board of directors, is pleased to announce the addition of Dr. Tina Sampalis to the Company's Board of Directors.

    Tina Sampalis, M.D., Ph.D., is an oncology surgeon trained in physiology at McGill University in Montreal, medicine at the University of Patras (Greece), dermatology at Göttingen University (Germany) and Marselisborg University (Denmark), pediatric, general and oncology surgery at the University of Athens (Greece), graduate training (Ph.D.) in Surgical Research at the University of Athens and a second Ph.D. in Epidemiology and Experimental Surgery at McGill University.

    Dr. Sampalis' leading work in Nutraceuticals includes Neptune Technologies & Bioressources, where she discovered one of the primary reasons krill oil is so beneficial to human health: Phospholipids. Dr. Sampalis is the named inventor of Neptune's composition and application patents. As the former President of Acasti Pharma Inc. she led the development of a novel patented active pharmaceutical ingredient targeting the prevention and treatment of hypertriglyceridemia and cardio metabolic-disorders.

    She is the Founder and President of the AGOO Children's Health & Wellness Center, a state-of-the-art multidisciplinary comprehensive, pediatric-adolescent medical center and accredited McGill University teaching site in Quebec.

    Dr. Sampalis has received several international scholarships and awards for her work on the clinical implementation of retinols for skin and breast cancer, including the Helen Hutchison Award for geriatric medicine. Her work on scintimammography resulted in her appointment at the International Educational Speakers Bureau, the Canadian and U.S. Faculty of Medical Speakers for Breast Imaging.

    As an international scholar, Dr. Sampalis leads the development and implementation of innovative micro-invasive and stereotactic robotic surgical techniques for breast cancer, for which a U.S. and Canadian patent application has been filed. She is a member of the American Association of Naturopathic Medicine. Dr. Sampalis has published papers in multiple peer-reviewed publications. She was named one of the 10 most successful women in Quebec (Les Affaires, 18-24 September 2010) and one of the 100 most successful globally by the Princeton Global Network.

    Relevium Technologies Inc. (TSX.V - "RLV") President and CEO, Aurelio Useche, stated, "We are very honored to have Dr. Sampalis join our Company. The addition of Dr. Sampalis closes the value chain by providing deep expertise in scientific and evidence based nutraceutical and medical trends, which can be leveraged through the consolidation of e-commerce assets such as BioGanix as announced on December 22, 2016."
     
  15. SleekyTrader

    SleekyTrader Member

    Joined:
    Jul 21, 2016
    Messages:
    51
    Likes Received:
    0
    Its taking off folks, not much for sale either
     
  16. kthanx

    kthanx Member

    Joined:
    Apr 5, 2016
    Messages:
    78
    Likes Received:
    5
    Sleeky - though I like the deal.

    My concern is how the funds will be raised for it. There are rumors that the Private Placement is going to come in at 10-12 cents.

    That would limit upside in the short term significantly - can you comment on this?
     
  17. SleekyTrader

    SleekyTrader Member

    Joined:
    Jul 21, 2016
    Messages:
    51
    Likes Received:
    0
    Even with a PP at 0.10$, the deal would value the stock at 0.47$ conservatively
     
  18. kthanx

    kthanx Member

    Joined:
    Apr 5, 2016
    Messages:
    78
    Likes Received:
    5
    Putting my trust in you this time - lets go for a ride with news.
     
  19. shellybear

    shellybear Member

    Joined:
    Feb 11, 2017
    Messages:
    122
    Likes Received:
    9
    Relevium halted this morning, perhaps financing news.
     
  20. kthanx

    kthanx Member

    Joined:
    Apr 5, 2016
    Messages:
    78
    Likes Received:
    5
    Averaged at around 0.12 and out at 0.19 - thanks for this opportunity!
     
    #20 kthanx, Mar 13, 2017
    Last edited: Mar 13, 2017

Share This Page